Natalia Di Ianni - Concepedia

Author

Natalia Di Ianni

Fondazione IRCCS Istituto Neurologico Carlo Besta ORCID

Also Known As

Di Ianni, Natalia, N Di Ianni, Natalia Di Ianni

Publications

718

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Neurologico Carlo Besta University of L'Aquila Sapienza University of Rome Harvard University University of North Carolina at Chapel Hill

About

Natalia Di Ianni is an author at Fondazione IRCCS Istituto Neurologico Carlo Besta specializing in medicine, cell biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	305
2	Cell Biology	4	4	260
3	Immunology	3	3	266
4	Cellular Physiology	1	1	15
5	Pathology	1	1	45

Natalia Di Ianni

Publications

649

Citations

H-Index

Page 1

	Year	Citations
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres Dean Nehama, Natalia Di Ianni, Silvia Musio, EBioMedicine	2019	179
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy Serena Pellegatta, Barbara Savoldo, Natalia Di Ianni, Science Translational Medicine Tumor InnervationImmunologyImmunoeditingImmunotherapeuticsImmunotherapy	2018	171
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells Antonietta R. Farina, Lucia Cappabianca, Giuseppina DeSantis, FEBS Letters Cancer ResearchTranscriptional RegulationBreast OncologyMmp-9 ExpressionSignaling Pathway	2011	50
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient Elena Anghileri, Natalia Di Ianni, Rosina Paterra, Cancer Immunology Immunotherapy MedicineImmunologyT-cell ActivationPathologyImmune Checkpoint Inhibitor	2020	45
Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma Cristina Corbetta, Natalia Di Ianni, Maria Grazia Bruzzone, International Journal of Cancer	2018	38
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma Sara Pessina, Gabriele Cantini, Dimos Kapetis, OncoImmunology	2015	34
Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy Marica Eoli, Cristina Corbetta, Elena Anghileri, Neuro-Oncology Advances	2019	33
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy Serena Pellegatta, Natalia Di Ianni, Sara Pessina, International Journal of Molecular Sciences	2019	25
The TrkAIII Oncoprotein Inhibits Mitochondrial Free Radical ROS-Induced Death of SH-SY5Y Neuroblastoma Cells by Augmenting SOD2 Expression and Activity at the Mitochondria, within the Context of a Tumour Stem Cell-like Phenotype Pierdomenico Ruggeri, Antonietta R. Farina, Natalia Di Ianni, PLoS ONE Reductive StressChemoprevention StrategyMitochondrial FunctionMitochondrial BiogenesisCell Death	2014	24
Constitutive autotaxin transcription by Nmyc‐amplified and non‐amplified neuroblastoma cells is regulated by a novel AP‐1 and SP‐mediated mechanism and abrogated by curcumin Antonietta R. Farina, Lucia Cappabianca, Pierdomenico Ruggeri, FEBS Letters	2012	23

Page 1